Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-043344
Filing Date
2013-08-06
Accepted
2013-08-06 17:02:27
Documents
12
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v351706_10q.htm 10-Q 315054
2 EXHIBIT 10.1 v351706_ex10-1.htm EX-10.1 2669
3 EXHIBIT 31.1 v351706_ex31-1.htm EX-31.1 9985
4 EXHIBIT 31.2 v351706_ex31-2.htm EX-31.2 9800
5 EXHIBIT 32.1 v351706_ex32-1.htm EX-32.1 4478
6 EXHIBIT 32.2 v351706_ex32-2.htm EX-32.2 4460
  Complete submission text file 0001144204-13-043344.txt   5263669

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT enzn-20130630.xml EX-101.INS 586965
8 XBRL TAXONOMY EXTENSION SCHEMA enzn-20130630.xsd EX-101.SCH 32849
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20130630_cal.xml EX-101.CAL 32333
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20130630_def.xml EX-101.DEF 165545
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20130630_lab.xml EX-101.LAB 238787
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20130630_pre.xml EX-101.PRE 204289
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12957 | Film No.: 131014299
SIC: 2836 Biological Products, (No Diagnostic Substances)